Literature DB >> 7818477

The kinetics, substrate and inhibitor specificity of the lactate transporter of Ehrlich-Lettre tumour cells studied with the intracellular pH indicator BCECF.

L Carpenter1, A P Halestrap.   

Abstract

1. Suspensions of cultured Ehrlich-Lettre tumour cells were loaded with the pH-sensitive fluorescent indicator 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein (BCECF), and changes in intracellular pH upon addition of L-lactate and other monocarboxylates were continuously monitored by fluorimetry using dual-wavelength excitation (450/500 nm) and single-wavelength emission (> 520 nm). 2. The rapid fluorescence changes were analysed by first-order regression analysis, and with suitable calibration procedures this enabled calculation of initial rates of proton uptake associated with monocarboxylate transport. 3. The stoichiometry was shown to be one proton per lactate molecule transported. 4. The kinetics of carrier-mediated transport of a wide range of monocarboxylates were determined at 25 degrees C. The Km values for L-lactate, pyruvate and D-lactate were found to be 4.54, 0.72 and 27.5 mM respectively, similar to values found previously for rat erythrocytes. This similarity was shared with a wide range of variously substituted C2, C3 and C4 monocarboxylates, all of which were transported with similar Vmax. No stereoselectivity was found in the Km values for D- and L-2-chloropropionate (0.75 mM) or D- and L-3-hydroxybutyrate (11 mM), but in the latter case the Vmax. of the D-isomer was twice that of the L-isomer. 5. The temperature-dependence of L-lactate transport demonstrated a transition point, with activation energies of 60 and 109 kJ.mol-1 above and below 19 degrees C respectively The Km for L-lactate below the transition temperature was about half that above it. 6. Inhibition of lactate transport into tumour cells by a wide range of compounds known to inhibit the erythrocyte monocarboxylate carrier was analysed. Patterns of inhibition were similar to those seen in the erythrocyte, but the Ki values were 2-4-fold higher in the tumour cells. 7. It is concluded that tumour cells contain an isoform of the monocarboxylate carrier with functional properties almost identical with that found in erythrocytes. This is probably identical with MCT1, which was recently cloned and sequenced from Chinese Hamster Ovary cells [Kim Garcia, Goldstein, Pathak, Anderson and Brown (1994) Cell 76, 865-873].

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7818477      PMCID: PMC1137398          DOI: 10.1042/bj3040751

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  43 in total

1.  Stereoselective, SH-dependent transfer of lactate in mammalian erythrocytes.

Authors:  B Deuticke; I Rickert; E Beyer
Journal:  Biochim Biophys Acta       Date:  1978-02-02

2.  The transport of branched-chain amino acids into isolated rat liver cells.

Authors:  J D McGivan; N M Bradford; J Mendes-Mourão
Journal:  FEBS Lett       Date:  1977-08-15       Impact factor: 4.124

3.  Transport of pyruvate nad lactate into human erythrocytes. Evidence for the involvement of the chloride carrier and a chloride-independent carrier.

Authors:  A P Halestrap
Journal:  Biochem J       Date:  1976-05-15       Impact factor: 3.857

4.  L-lactate transport in Ehrlich ascites-tumour cells.

Authors:  T L Spencer; A L Lehninger
Journal:  Biochem J       Date:  1976-02-15       Impact factor: 3.857

5.  Inhibition of mitochondrial pyruvate transport by phenylpyruvate and alpha-ketoisocaproate.

Authors:  A P Halestrap; M D Brand; R M Denton
Journal:  Biochim Biophys Acta       Date:  1974-10-10

6.  Sublines of the Ehrlich-Lettré mouse ascites tumour. A new tool for experimental cell research.

Authors:  R Lettré; N Paweletz; D Werner; C Granzow
Journal:  Naturwissenschaften       Date:  1972-02

7.  Substrate and inhibitor specificity of monocarboxylate transport into heart cells and erythrocytes. Further evidence for the existence of two distinct carriers.

Authors:  R C Poole; S L Cranmer; A P Halestrap; A J Levi
Journal:  Biochem J       Date:  1990-08-01       Impact factor: 3.857

8.  Characterization of beta-hydroxybutyrate transport in rat erythrocytes and thymocytes.

Authors:  B L Andersen; H T Tarpley; D M Regen
Journal:  Biochim Biophys Acta       Date:  1978-04-20

9.  Specific inhibition of pyruvate transport in rat liver mitochondria and human erythrocytes by alpha-cyano-4-hydroxycinnamate.

Authors:  A P Halestrap; R M Denton
Journal:  Biochem J       Date:  1974-02       Impact factor: 3.857

10.  Transport of hexoses across the liver-cell membrane.

Authors:  H Baur; H W Heldt
Journal:  Eur J Biochem       Date:  1977-04-01
View more
  53 in total

1.  Monocarboxylate transporter 2 and stroke severity in a rodent model of sleep apnea.

Authors:  Yang Wang; Shang Z Guo; Arend Bonen; Richard C Li; Leila Kheirandish-Gozal; Shelley X L Zhang; Kenneth R Brittian; David Gozal
Journal:  J Neurosci       Date:  2011-07-13       Impact factor: 6.167

2.  Discrimination of two amino acid transport activities in 4F2 heavy chain- expressing Xenopus laevis oocytes.

Authors:  A Bröer; B Hamprecht; S Bröer
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

3.  Significance of short chain fatty acid transport by members of the monocarboxylate transporter family (MCT).

Authors:  Ivano Moschen; Angelika Bröer; Sandra Galić; Florian Lang; Stefan Bröer
Journal:  Neurochem Res       Date:  2012-08-10       Impact factor: 3.996

4.  Cloning of the monocarboxylate transporter isoform MCT2 from rat testis provides evidence that expression in tissues is species-specific and may involve post-transcriptional regulation.

Authors:  V N Jackson; N T Price; L Carpenter; A P Halestrap
Journal:  Biochem J       Date:  1997-06-01       Impact factor: 3.857

Review 5.  β-Hydroxybutyrate in the Brain: One Molecule, Multiple Mechanisms.

Authors:  Lavanya B Achanta; Caroline D Rae
Journal:  Neurochem Res       Date:  2016-11-08       Impact factor: 3.996

Review 6.  The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond.

Authors:  Andrew P Halestrap; David Meredith
Journal:  Pflugers Arch       Date:  2003-05-09       Impact factor: 3.657

7.  The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition.

Authors:  Anna W C Leung; Pinadda Varanyuwatana; Andrew P Halestrap
Journal:  J Biol Chem       Date:  2008-07-30       Impact factor: 5.157

8.  Identification and characterization of a monocarboxylate transporter (MCT1) in pig and human colon: its potential to transport L-lactate as well as butyrate.

Authors:  A Ritzhaupt; I S Wood; A Ellis; K B Hosie; S P Shirazi-Beechey
Journal:  J Physiol       Date:  1998-12-15       Impact factor: 5.182

9.  Studies on the DIDS-binding site of monocarboxylate transporter 1 suggest a homology model of the open conformation and a plausible translocation cycle.

Authors:  Marieangela C Wilson; David Meredith; Chotirote Bunnun; Richard B Sessions; Andrew P Halestrap
Journal:  J Biol Chem       Date:  2009-05-27       Impact factor: 5.157

10.  AR-C155858 is a potent inhibitor of monocarboxylate transporters MCT1 and MCT2 that binds to an intracellular site involving transmembrane helices 7-10.

Authors:  Matthew J Ovens; Andrew J Davies; Marieangela C Wilson; Clare M Murray; Andrew P Halestrap
Journal:  Biochem J       Date:  2010-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.